HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Katoh Selected Research

Akira Katoh Research Topics

Disease

2Neoplasms (Cancer)
08/2021 - 12/2019
2Fibrosis (Cirrhosis)
12/2019 - 12/2019
2Type 2 Diabetes Mellitus (MODY)
10/2010 - 07/2006
2Insulin Resistance
10/2010 - 07/2006
1Smith-Lemli-Opitz Syndrome
04/2024
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2022
1Endometriosis
12/2019
1Cysts
12/2019
1Skin Diseases (Skin Disease)
12/2019
1Atopic Dermatitis (Atopic Eczema)
12/2019
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2019
1Dermatitis
12/2019
1Asthma (Bronchial Asthma)
12/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2010
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2010
1Obesity
07/2006
1Hypertension (High Blood Pressure)
07/2006
1Diabetes Mellitus
06/2006

Drug/Important Bio-Agent (IBA)

3CateninsIBA
02/2022 - 12/2019
3ICG 001IBA
02/2022 - 12/2019
2Insulin (Novolin)FDA Link
10/2010 - 06/2006
17-dehydrocholesterolIBA
04/2024
1CholesterolIBA
04/2024
1ChromatinIBA
02/2022
1RNA (Ribonucleic Acid)IBA
02/2022
1Antiviral Agents (Antivirals)IBA
08/2021
1Peptides (Polypeptides)IBA
08/2021
1CREB-Binding ProteinIBA
12/2019
1Thymic Stromal LymphopoietinIBA
12/2019
1HaptensIBA
12/2019
1Chemokine CCL17IBA
12/2019
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
12/2019
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2010
1MetalsIBA
10/2010
1allixinIBA
10/2010
1SulfurIBA
10/2010
1ZincIBA
10/2010
1LeptinIBA
07/2006
1bis(allixinato)oxovanadium(IV)IBA
07/2006
1VanadiumIBA
07/2006

Therapy/Procedure

2Injections
10/2010 - 06/2006
1Aftercare (After-Treatment)
12/2019
1Therapeutics
12/2019
1Oral Administration
07/2006